Medical specialists from Norway tagged as investigators in clinical trials studying Multiple Sclerosis
Total 13 results
-
Christopher Elnan Kvistad, PhDSeen in:
- Vestland, Bergen, Haukeland University Hospital
Trials:- NCT04749667 (Principal Investigator)
Conditions: -
Einar August Høgestøl, MD, PhDfellSeen in:
- Oslo, Department of Neurology, Oslo University Hospital
Trials:- NCT04121403 (Sub-Investigator)
Conditions: -
Elisabeth Gulowsen Celius, MD, dr medSeen in:
- Oslo, Department of Neurology, Oslo University Hospital
Trials:- NCT04121403 (Sub-Investigator)
Conditions: -
Hiba Bashari, MDSeen in:
- Oslo, Department of Neurology, Oslo University Hospital
Trials:- NCT04121403 (Sub-Investigator)
Conditions: -
Hilde Norborg, MDSeen in:
- Bergen, Neuro-SysMed, Dept. of Neurology, Haukeland University Hospital, & Dept. of Clinical Medicine, University of Bergen
Trials:- NCT04904016 (Sub-Investigator)
Conditions: -
Iselin Marie Wedding, MD, PhDSeen in:
- Oslo, Department of Neurology, Oslo University Hospital
Trials:- NCT04121403 (Sub-Investigator)
Conditions: -
Kennet Idland, MDSeen in:
- Vestfold, Tønsberg, Department of Neurology - Tønsberg, Sykehuset i Vestfold HF
Trials:- NCT04121403 (Sub-Investigator)
Conditions: -
Kristin Wesens, PhDSeen in:
- Trøndelag, Trondheim, St.Olav university hospital
Trials:- NCT04749667 (Principal Investigator)
Conditions: -
Lars Bø, MD, PhDSeen in:
- Bergen, Haukeland University Hospital
Trials:- NCT04578639 (Sub-Investigator)
Conditions: -
Linn Steffensen, PhDSeen in:
- Troms Og Finnmark, Tromsø, University Hospital of North Norway
Trials:- NCT04749667 (Principal Investigator)
Conditions: -
Pål Berg-Hansen, MD, PhDSeen in:
- Oslo, Department of Neurology, Oslo University Hospital
Trials:- NCT04121403 (Sub-Investigator)
Conditions: -
Stig Wergeland, MD, PhDSeen in:
- Bergen, Haukeland University Hospital
Trials:- NCT04578639 (Sub-Investigator)
Conditions: -
Trygve Holmøy, ProfSeen in:
- Viken, Lørenskog, Akershus University Hospital
Trials:- NCT04749667 (Principal Investigator)
Conditions:
Clinical Trials on Multiple Sclerosis
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationRecruitingMultiple Sclerosis (MS) | Relapsing-remitting Multiple Sclerosis (RRMS) | Secondary-progressive Multiple Sclerosis (SPMS) | Primary Progressive Multiple Sclerosis (PPMS)Switzerland
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent ProgressiveJapan
-
The Cleveland ClinicUniversity Hospitals Cleveland Medical CenterCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
Rigshospitalet, DenmarkOdense University Hospital; Aarhus University Hospital; Hvidovre University Hospital and other collaboratorsActive, not recruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
University of California, San FranciscoUnited States Department of DefenseRecruitingMultiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis (MS) | Multiple Sclerosis Relapse | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis Brain Lesion | Multiple Sclerosis BenignUnited States
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Queen Mary University of LondonTakeda Pharmaceuticals International, Inc.RecruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited Kingdom
-
Banc de Sang i TeixitsVall d'Hebron Research Institute (VHIR)CompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisSpain
-
BiogenElan PharmaceuticalsCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States